JP2008520660A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008520660A5 JP2008520660A5 JP2007542974A JP2007542974A JP2008520660A5 JP 2008520660 A5 JP2008520660 A5 JP 2008520660A5 JP 2007542974 A JP2007542974 A JP 2007542974A JP 2007542974 A JP2007542974 A JP 2007542974A JP 2008520660 A5 JP2008520660 A5 JP 2008520660A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- amino acid
- group
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 29
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 125000000539 amino acid group Chemical group 0.000 claims 6
- 208000015181 infectious disease Diseases 0.000 claims 5
- 101710187798 60S ribosomal protein L23 Proteins 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 102220595263 Minor histocompatibility protein HB-1_H16A_mutation Human genes 0.000 claims 3
- 206010052428 Wound Diseases 0.000 claims 3
- 208000027418 Wounds and injury Diseases 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- -1 aminoglycoside Chemical compound 0.000 claims 3
- 230000000813 microbial effect Effects 0.000 claims 3
- 244000005700 microbiome Species 0.000 claims 3
- 229920001184 polypeptide Polymers 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 102220511881 Acyl-coenzyme A thioesterase THEM4_L17R_mutation Human genes 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 2
- 102220638984 Beta-enolase_H16K_mutation Human genes 0.000 claims 2
- 102220591050 Cellular tumor antigen p53_S15A_mutation Human genes 0.000 claims 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 2
- 102220554117 Cyclic GMP-AMP synthase_L17T_mutation Human genes 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- 241000233866 Fungi Species 0.000 claims 2
- 101001118566 Homo sapiens 40S ribosomal protein S15a Proteins 0.000 claims 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims 2
- 102220632609 Immunoglobulin heavy variable 1-69_L17A_mutation Human genes 0.000 claims 2
- 102220479923 Leucine-rich repeat-containing protein 26_H11A_mutation Human genes 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 102220595270 Minor histocompatibility protein HB-1_H16R_mutation Human genes 0.000 claims 2
- 102220559160 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial_S15T_mutation Human genes 0.000 claims 2
- 102220493626 Paired box protein Pax-6_G18W_mutation Human genes 0.000 claims 2
- 102220574876 Putative uncharacterized protein YWHAH-AS1_H11L_mutation Human genes 0.000 claims 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 2
- 230000000845 anti-microbial effect Effects 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- 229910052802 copper Inorganic materials 0.000 claims 2
- 239000010949 copper Substances 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- 244000045947 parasite Species 0.000 claims 2
- 238000011321 prophylaxis Methods 0.000 claims 2
- 102220183613 rs138041990 Human genes 0.000 claims 2
- 102200148728 rs200185747 Human genes 0.000 claims 2
- 102200038952 rs3762568 Human genes 0.000 claims 2
- 102220172525 rs748464893 Human genes 0.000 claims 2
- 102220093468 rs759289686 Human genes 0.000 claims 2
- 102220079367 rs797045802 Human genes 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 239000011701 zinc Substances 0.000 claims 2
- 229910052725 zinc Inorganic materials 0.000 claims 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 claims 1
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 claims 1
- 229940123208 Biguanide Drugs 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 241000282832 Camelidae Species 0.000 claims 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 1
- 241000222122 Candida albicans Species 0.000 claims 1
- 241000222173 Candida parapsilosis Species 0.000 claims 1
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- 102220582890 Cellular tumor antigen p53_S15R_mutation Human genes 0.000 claims 1
- 229930186147 Cephalosporin Natural products 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims 1
- 241000194032 Enterococcus faecalis Species 0.000 claims 1
- 241000283086 Equidae Species 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 102000002068 Glycopeptides Human genes 0.000 claims 1
- 108010015899 Glycopeptides Proteins 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 206010021531 Impetigo Diseases 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 201000005505 Measles Diseases 0.000 claims 1
- 206010027236 Meningitis fungal Diseases 0.000 claims 1
- 102220515779 Methionine-R-sulfoxide reductase B1_A14V_mutation Human genes 0.000 claims 1
- 102220515780 Methionine-R-sulfoxide reductase B1_A14Y_mutation Human genes 0.000 claims 1
- 206010050346 Oropharyngeal candidiasis Diseases 0.000 claims 1
- 229930182555 Penicillin Natural products 0.000 claims 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 229920002413 Polyhexanide Polymers 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 241000588770 Proteus mirabilis Species 0.000 claims 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 1
- 206010039792 Seborrhoea Diseases 0.000 claims 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims 1
- 206010040943 Skin Ulcer Diseases 0.000 claims 1
- 208000028990 Skin injury Diseases 0.000 claims 1
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 241000193996 Streptococcus pyogenes Species 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- 239000004098 Tetracycline Substances 0.000 claims 1
- 208000007536 Thrombosis Diseases 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 206010046914 Vaginal infection Diseases 0.000 claims 1
- 201000008100 Vaginitis Diseases 0.000 claims 1
- 229960000583 acetic acid Drugs 0.000 claims 1
- 230000021736 acetylation Effects 0.000 claims 1
- 238000006640 acetylation reaction Methods 0.000 claims 1
- 230000009692 acute damage Effects 0.000 claims 1
- 230000010933 acylation Effects 0.000 claims 1
- 238000005917 acylation reaction Methods 0.000 claims 1
- 239000000853 adhesive Substances 0.000 claims 1
- 230000001070 adhesive effect Effects 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 230000029936 alkylation Effects 0.000 claims 1
- 238000005804 alkylation reaction Methods 0.000 claims 1
- 230000009435 amidation Effects 0.000 claims 1
- 238000007112 amidation reaction Methods 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 229940126575 aminoglycoside Drugs 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000003255 anti-acne Effects 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 claims 1
- 229960003644 aztreonam Drugs 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 229940095731 candida albicans Drugs 0.000 claims 1
- 229940055022 candida parapsilosis Drugs 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- JSVCEVCSANKFDY-SFYZADRCSA-N carbacephem Chemical compound C1CC(C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)C)[C@H]21 JSVCEVCSANKFDY-SFYZADRCSA-N 0.000 claims 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 claims 1
- 229940124587 cephalosporin Drugs 0.000 claims 1
- 150000001780 cephalosporins Chemical class 0.000 claims 1
- UCKZMPLVLCKKMO-LHLIQPBNSA-N cephamycin Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](C)[C@]21OC UCKZMPLVLCKKMO-LHLIQPBNSA-N 0.000 claims 1
- 229940045110 chitosan Drugs 0.000 claims 1
- 229960003260 chlorhexidine Drugs 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 229940108928 copper Drugs 0.000 claims 1
- 208000005035 cutaneous candidiasis Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 229940032049 enterococcus faecalis Drugs 0.000 claims 1
- 230000032050 esterification Effects 0.000 claims 1
- 238000005886 esterification reaction Methods 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 229940124307 fluoroquinolone Drugs 0.000 claims 1
- 201000010056 fungal meningitis Diseases 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 239000003120 macrolide antibiotic agent Substances 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 206010033072 otitis externa Diseases 0.000 claims 1
- 230000006320 pegylation Effects 0.000 claims 1
- 229940049954 penicillin Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229940093158 polyhexanide Drugs 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 claims 1
- 102200009633 rs12263012 Human genes 0.000 claims 1
- 102200142069 rs2577154 Human genes 0.000 claims 1
- 208000008742 seborrheic dermatitis Diseases 0.000 claims 1
- 239000002453 shampoo Substances 0.000 claims 1
- 229910052709 silver Inorganic materials 0.000 claims 1
- 239000004332 silver Substances 0.000 claims 1
- 229940009188 silver Drugs 0.000 claims 1
- 239000000344 soap Substances 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 229960002180 tetracycline Drugs 0.000 claims 1
- 229930101283 tetracycline Natural products 0.000 claims 1
- 235000019364 tetracycline Nutrition 0.000 claims 1
- 150000003522 tetracyclines Chemical class 0.000 claims 1
- 239000000606 toothpaste Substances 0.000 claims 1
- 238000011282 treatment Methods 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62811004P | 2004-11-17 | 2004-11-17 | |
| SE0402807A SE0402807D0 (sv) | 2004-11-17 | 2004-11-17 | Novel antimicrobial peptides |
| SE0402807-2 | 2004-11-17 | ||
| US60/628,110 | 2004-11-17 | ||
| PCT/SE2005/001737 WO2006054947A1 (en) | 2004-11-17 | 2005-11-17 | Novel antimicrobial peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008520660A JP2008520660A (ja) | 2008-06-19 |
| JP2008520660A5 true JP2008520660A5 (enExample) | 2008-12-11 |
| JP4898698B2 JP4898698B2 (ja) | 2012-03-21 |
Family
ID=33488268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007542974A Expired - Fee Related JP4898698B2 (ja) | 2004-11-17 | 2005-11-17 | 新規抗菌性ペプチド |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080069849A1 (enExample) |
| EP (1) | EP1817046A4 (enExample) |
| JP (1) | JP4898698B2 (enExample) |
| KR (1) | KR20070108142A (enExample) |
| CN (1) | CN101068563B (enExample) |
| AU (1) | AU2005307160B2 (enExample) |
| CA (1) | CA2588145A1 (enExample) |
| SE (1) | SE0402807D0 (enExample) |
| WO (1) | WO2006054947A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2637221A1 (en) * | 2006-02-10 | 2007-08-16 | Dermagen Ab | Novel antimicrobial peptides and use thereof |
| CA2637216A1 (en) * | 2006-02-10 | 2007-08-16 | Dermagen Ab | Novel antimicrobial peptides and use thereof |
| JP5330230B2 (ja) * | 2006-05-16 | 2013-10-30 | ペルガモン アクティエボラーグ | 改良型抗菌ペプチド |
| JP5384948B2 (ja) * | 2007-02-09 | 2014-01-08 | ジェノミディア株式会社 | 新規ポリペプチド及びそれを有効成分として含有する抗菌剤 |
| WO2010019651A1 (en) * | 2008-08-13 | 2010-02-18 | Dow Global Technologies Inc. | Peptide-coated fibers |
| EP2318584A1 (en) * | 2008-08-13 | 2011-05-11 | Dow Global Technologies LLC | Process of fabricating peptide-coated fibers |
| ES2467691T3 (es) * | 2008-11-28 | 2014-06-12 | Anges Mg, Inc. | Polipéptido novedoso que tiene actividad de inducción de la angiogénesis y una actividad antibacteriana y uso del mismo para propósitos médicos |
| US20100184684A1 (en) * | 2009-01-06 | 2010-07-22 | C3 Jian, Inc. | Antibacterial and antifungal peptides |
| WO2010101237A1 (ja) | 2009-03-06 | 2010-09-10 | アンジェスＭｇ株式会社 | ポリペプチド及びその抗菌または消毒用途 |
| JP5750766B2 (ja) | 2009-05-25 | 2015-07-22 | 株式会社ファンペップ | 血管新生誘導活性及び抗菌活性を有するポリペプチドおよびそれを含有する創傷治療剤 |
| CN102596925A (zh) * | 2009-06-08 | 2012-07-18 | 马萨诸塞州大学 | 抗微生物聚合物 |
| WO2017001731A1 (en) * | 2015-06-30 | 2017-01-05 | Oulun Yliopisto | New antimicrobial peptides, their variants and uses |
| KR101855170B1 (ko) * | 2015-11-18 | 2018-05-08 | (주)노바셀테크놀로지 | 신규 항균 펩타이드 및 그의 용도 |
| CN108324922A (zh) * | 2018-04-16 | 2018-07-27 | 赵成群 | 一种预防和治疗妇科炎症的凝胶组合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5912230A (en) * | 1991-11-01 | 1999-06-15 | Periodontix, Inc. | Anti-fungal and anti-bacterial histatin-based peptides |
| US5593866A (en) * | 1992-08-21 | 1997-01-14 | The University Of British Columbia | Cationic peptides and method for production |
| US5733872A (en) * | 1993-03-12 | 1998-03-31 | Xoma Corporation | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| AU1086595A (en) * | 1993-11-08 | 1995-05-29 | Demeter Biotechnologies, Ltd. | Methylated lysine-rich lytic peptides and method of making same by reductive alkylation |
| JP3459314B2 (ja) * | 1994-08-31 | 2003-10-20 | 社団法人農林水産技術情報協会 | 新規ペプチド、抗菌剤、新規ペプチド遺伝子、新規な組み換え体ｄｎａ及び新規ペプチドの製造法 |
| US6503881B2 (en) * | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| IL121134A0 (en) * | 1997-06-22 | 1997-11-20 | Yeda Res & Dev | Peptides and antiallergic compositions comprising them |
| SE0301431D0 (sv) * | 2003-05-19 | 2003-05-19 | Dermagen | Novel antimicrobial peptides |
| WO2007001457A2 (en) * | 2004-11-12 | 2007-01-04 | Xencor, Inc. | Antibodies operably linked to selected chemoattractants |
-
2004
- 2004-11-17 SE SE0402807A patent/SE0402807D0/sv unknown
-
2005
- 2005-11-17 WO PCT/SE2005/001737 patent/WO2006054947A1/en not_active Ceased
- 2005-11-17 US US11/718,861 patent/US20080069849A1/en not_active Abandoned
- 2005-11-17 CA CA002588145A patent/CA2588145A1/en not_active Abandoned
- 2005-11-17 CN CN2005800416016A patent/CN101068563B/zh not_active Expired - Fee Related
- 2005-11-17 AU AU2005307160A patent/AU2005307160B2/en not_active Ceased
- 2005-11-17 KR KR1020077013664A patent/KR20070108142A/ko not_active Ceased
- 2005-11-17 JP JP2007542974A patent/JP4898698B2/ja not_active Expired - Fee Related
- 2005-11-17 EP EP05807139A patent/EP1817046A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008520660A5 (enExample) | ||
| JP6483058B2 (ja) | 抗菌剤と分散剤または接着阻害剤組成物 | |
| JP2015504921A5 (enExample) | ||
| CN101573031A (zh) | 抗微生物组合物 | |
| DE69331953D1 (de) | Antimikrobielle polypeptide | |
| JP2010254697A (ja) | 架橋されたグリコペプチド−セファロスポリン抗生物質 | |
| JP2012513467A5 (enExample) | ||
| WO2020061375A8 (en) | Antibacterial compounds | |
| JP2020516582A (ja) | 銀および抗生物質を含むナノシステムならびに細菌感染症の治療のための使用 | |
| RU2011130278A (ru) | Новые противобактериальные средства для лечения грамположительных инфекций | |
| JP2011528354A5 (enExample) | ||
| JP2020536966A5 (enExample) | ||
| WO2005070945A8 (ja) | メチシリン耐性黄色ブドウ球菌（ｍｒｓａ）に有効な新規アミノグリコシド系抗生物質 | |
| JP2024009968A5 (enExample) | ||
| JP2018521143A5 (enExample) | ||
| ES2942848T3 (es) | Derivados de tiofeno-2-amida sustituidos con difenilo y composiciones farmacéuticas de los mismos útiles como antimicrobiano | |
| WO2009124086A3 (en) | Antibacterial drug for treatment of staphylococcus aureus and other gram-positive bacterial infections | |
| JP2004175733A (ja) | 薬剤耐性菌による感染症治療剤 | |
| WO2017212239A1 (en) | Treatment of drug-resistant microbial infections | |
| Shariatifar et al. | In-vitro antibacterial evaluation of some fluoroquinolone derivatives against food borne bacteria | |
| WO2021160234A4 (en) | Antimicrobial peptides from medicinal leeches | |
| Salazar | Use of antibiotics and NSAID drugs to inhibit Staphylococcus aureus biofilm formation | |
| Watanabe et al. | Comparative in vitro activity of carbapenem antibiotics against respiratory pathogens isolated in recent years | |
| JPWO2019169479A5 (enExample) | ||
| Kondrashev | The Etiology of Chronic Purulent Maxillary Sinusitis |